Summary
C3H/He mice were inoculated i.v. with 106 heavily X-irradiated syngeneic X5563 plasmacytoma cells 3 times at 4 day intervals. When these mice received an appropriate immunization procedure consisting of i. d. inoculation of viable tumor cells plus the surgical resection of the tumor which enables i.v. nonpresensitized mice to produce anti-X5563 immunity, they failed to develop tumor-specific immunity. This was demonstrated by the abrogation in potential of spleen and lymph node cells to generate in vivo protective immunity. In contrast, the tumor mass from X5563 tumor-bearing mice which had received the i.v. presensitization contained comparable anti-X5563 tumor neutralizing activity to that obtained from the tumor mass from nonpresensitized, X5563 tumor-bearing mice. Such an in vivo protective immunity was revealed to be mediated by tumor-specific T cells. These results demonstrate the differential generation and antitumor capability of tumor infiltrating T cells and T cells in lymphoid organs from mice which are in the tumor-specific tolerant state. The results are discussed in the context of potential utilization of tumor infiltrating in vivo protective T cells to enhance the local tumor-specific immunity in tumor-specific tolerant mice.
Similar content being viewed by others
References
Buessow SC, Paul RD, Lopez DM (1984) Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice. J Natl Cancer Inst 73:249
Fujimoto S, Greene MI, Sehon AA (1976) Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing mice. J Immunol 116:791
Fujiwara H, Hamaoka T, Kitagawa M (1978) Suppressive effect of pretreatment with X-irradiated tumor cells on the induction of syngeneic murine tumor system. I. Suppressive versus sensitizing effect on the same pretreatment in 2 tumor systems with different immune resaponses. Gann 69:793
Fujiwara H, Tsuchida T, Mizuochi T, Kohmo T, Hamaoka T (1981) Suppressive effect of X-irradiated tumor cell presensitization on the induction of syngeneic tumor immunity. III. The mechanism of specific suppression in effector T cell clones against tumor-associated transplantation antigens. Gann 72:732
Fujiwara H, Aoki H, Yoshioka T, Tomita S, Ikegami R, Hamaoka T (1984) Estanblishment of tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to autochthonous tumor system. J Immunol 133:509
Fujiawara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T (1984) The role of tumor-specific lyt-1+2− T cells in eradicating tumor cells in vivo. I Lyt-1+2− T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. J Immunol 133:1671
Fujiwara H, Moriyama Y, Suda T, Tsuchida T, Shearer GM, Hamaoka T (1984) Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity which results in tumor regression. J Immunol 132:1517
Fujiwara H, Sato S, Kosugi A, Fukuzawa M, Hamaoka T (1987) Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potentials to reconstitute tumor-specific effector T cell clones. Cancer Immunol Immunother 24:113
Glaser M, Herberman RB, Kirchner H, Djeu JY (1974) Study of cellular immune response to Gross virus induced lymphoma by mixted lymphocyte-tumor cell interaction. Cancer Res 34:2165
Gorczynski RM (1974) Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals. J Immunol 112:533
Hellstrom KE, Hellstrom I (1974) Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol 18:209
Herberman RB, Holden HT, Varesio L, Taniyama T, Puccetti P, Kirchner H, Gerson J, White S, Keisari Y, Haskill JS, (1980) Immunologic reactivity of lymphoid cells in tumors. Contemp Top Immunobiol 10:61
Ibayashi Y, Ueda T, Ueda T, Kikuchi K (1985) Functional analysis of mononuclear cells infiltrating into tumors: differential cytotoxicity of mononuclear cells from tumors of immune and nonimmune rats. J Immunol 134:648
Ishii Y, Matsuura A, Takami T, Ueda T, Ibayashi Y, Ueda T, Imamura M, Kikuchi K, Kikuchi Y (1984) Lymphoid cell subpopulations infiltrating into autologous rat tumors undergoing rejection. Cancer Res 44:4053
Jones JA, Robinson G, Rees RC, Baldwin RW (1978) Immune response of the draining and distal lymph nodes during the progressive growth of a chemically induced transplantable rat hepatoma. Int J Cancer 21:171
Kamo I, Friedmen H (1977) Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 25:271
Kasahara T, Nakano K, Shioiri, Sugiura A (1977) Detection of mitogen-activated T and non-T lymphocytes by virus plaque assay. Virus plaque assay on the cells fractionated by unit gravity sedimentation. Immunology 32:875
Leclere JC, Cantor H (1980) T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursors and effector cytolytic T lymphocytes. J Immunol 124:846
Leclerc JC, Gomard E, Plata F, Levy JP (1973) Cell-mediated reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor cell cytolysis. Int J Cancer 11:426
Levy JP, Leclerc JC (1977) The murine sarcoma virus-induced tumor: exception or general model in tumor immunology. Adv Cancer Res 24:1
Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318
Russel SW, Doe WF, Hoskins RG, Cochrane CG (1976) Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells. Int J Cancer 18:322
Tomita S, Fujiwara H, Yamane Y, Sano S, Nakajima H, Izumi Y, Arai H. Kawanishi Y, Tsuchida T, Hamaoka T (1986) Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2− T cells mediating delayed type-hypersensitivity response and in vivo protective immunity. Gann 77:182
Author information
Authors and Affiliations
Additional information
This work was supported by Special Project Research-Cancer Bioscience from the Ministry of Education, Science and Culture
Rights and permissions
About this article
Cite this article
Sano, S., Izumi, Y., Sugihara, S. et al. The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens. Cancer Immunol Immunother 25, 105–110 (1987). https://doi.org/10.1007/BF00199949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199949